Mindstrong Health recently helped raise $14 million to help fund the diagnosis and treatment of neuropsychiatric treatment. This money was raised in a Series A financing in an event organized in June this year.
Mindstrong Health’s new venture
Mindstrong Health is a platform that links the brain function to smartphones to measure cognitive abilities. This company is dedicated to monitoring digital biomarkers of cognition and mood. According to Mindstrong Health’s co-founder, Dr. Tom Insel, this test is aimed at improving mental health given that it is one of the top global health problems. In a press release on Bloomberg, Tananbaum revealed that Mindstrong was headed for prosperity due to the collaborative leadership comprised of professionals, such as Rick, Tom, and Paul. He also added by posting on Twitter that these executives are not only business oriented but focused on improving the health of their patients. Dr. Paul Dagum, the current chief executive officer of the company, also congratulated the firm for developing new measures for dealing with chronic diseases.
About Jim Tananbaum
Jim Tananbaum is a businessman and the current executive of Foresite Capital Management, reveals businesswire.com. He is experienced in the field of biotechnology, start-ups development, and venture capital management. Tananbaum is a graduate of Yale University, the Massachusetts Institute of Technology, and Harvard business and medical school. He has two masters’ degrees in business administration and information technology. Jim Tananbaum has worked for various biotechnology companies in the last two decades.
Throughout his career, Tananbaum held various executive positions and helped the companies he worked for expand their territories. He is the founder of GelTex, the leading manufacturer of non-systemic drugs. He worked with this firm for two years before selling it for $1.6 billion. In 1993, he joined Sierra Ventures where he helped the company build a health service investment network. During his tenure in this enterprise, Tananbaum led investments at CareSelect, Novamed, and Amerigroup. He has also worked for Theravance for three years as the firm’s CEO. Jim Tananbaum has also worked for Prospect Venture Partners as the managing director. At the Foresite Capital Management, he handles matters pertaining healthcare investment funds as well as administrative issues.